Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Scientists Limit Accelerated Cellular Aging Caused by Methamphetamine Use

February 13, 2015 10:41 am | by UC Irvine | News | Comments

The ravaged faces of methamphetamine addicts tell a terrible tale – abusing the drug dramatically accelerates aging. Read more...                      

TOPICS:

Drug Abuse in Iran Rising Despite Executions, Police Raids

February 13, 2015 10:34 am | by Ali Akbar Dareini - Associated Press | News | Comments

Officials say methamphetamine production and abuse of hard drugs are skyrocketing in the country despite potentially lethal criminal penalties for users if they are caught. Read more...            

TOPICS:

Disney Gave Input on Measles Health Message

February 13, 2015 10:28 am | by Amy Taxin and Alicia Chang - Associated Press | News | Comments

As the measles outbreak spread last month, Disneyland executives sent a series of emails to California health officials asking them to emphasize that the theme park was not responsible for the illnesses and was safe to visit. Read more...    

TOPICS:
Advertisement

New Drug Development to Focus on the Genetics of Cervical Cancer

February 13, 2015 8:57 am | by University of Huddersfield | News | Comments

University of Huddersfield researcher Dr Tsitsi Chituku is taking part in a project that seeks to learn more about the genetic factors that make some women more susceptible to cervical cancer.  It was a recent visit to Africa, to carry out a health screening project involving hundreds of women, which helped to shape the emphasis of her research. Read more...

TOPICS:

Possible Mechanism Underpinning Alzheimer's, Parkinson's

February 12, 2015 4:08 pm | by Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time discovered a killing mechanism that could underpin a range of the most intractable neurodegenerative diseases such as Alzheimer's, Parkinson's and ALS. Read more..

TOPICS:

Closing the Knowledge Gap on Cancer Drug Toxicity

February 12, 2015 3:59 pm | by David Jackson, Ph.D., Chief Innovation Officer, MolecularHealth | Articles | Comments

There is a dangerous knowledge gap in the use of cancer medications that needs to be closed, immediately. Read more...                                                          

TOPICS:

Researchers Design 'Evolutionary Trap' to Thwart Drug Resistance

February 12, 2015 3:48 pm | by Stowers Institute for Medical Research | News | Comments

Cancer is a notoriously evasive disease. It can adopt multiple identities, accumulating mutations or even gaining or losing whole chromosomes to create genetic variants of itself that are resistant to whatever drug is thrown its way. Read more...   

Key to Blocking Flu Virus May Lie in a Cell's Machinery

February 12, 2015 3:35 pm | by Rockefeller University | News | Comments

Viruses are masters of outsourcing, entrusting their fundamental function - reproduction - to the host cells they infect. But it turns out this highly economical approach also creates vulnerability. Read more...                

TOPICS:
Advertisement

BioMed Realty Breaks Ground on Life Science Development

February 12, 2015 2:55 pm | News | Comments

​Joined by San Diego political leaders and representatives of the life science community, BioMed Realty Trust, Inc. broke ground on a new 316,000 square foot laboratory and office campus designed to meet the unique real estate needs of San Diego's thriving life science industry. Read more...

TOPICS:

Crowdfunding Helps Solve Rare Disease Mystery

February 12, 2015 2:40 pm | by Tel Aviv University | News | Comments

Rare diseases — those that affect fewer than one in 200,000 people — are often identified early in life. Some 30 percent of children afflicted by these "orphan diseases" do not live to see their fifth birthday. Read more...

TOPICS:

Science is Afire With Plans to Help Smokers Quit

February 12, 2015 12:25 pm | by Cynthia Fox, Science Editor | Articles | Comments

All types of scientists are at work, on all kinds of quit-smoking aids, from an anti-smoking vaccine to a biomarker test. Read more...                                         

TOPICS:

Commuter with Measles Prompts California Transit Warning

February 12, 2015 11:48 am | by Paul Elias, Associated Press | News | Comments

​Officials in Northern California on Wednesday warned Bay Area Rapid Transit commuters that they may have been exposed to measles after an infected LinkedIn employee used the trains. Read more...                 

TOPICS:

Eisai's Thyroid Cancer Drug: Phase 3 Trial

February 12, 2015 11:38 am | News | Comments

Results from the pivotal Phase 3 SELECT (Study of (E7080) Lenvatinib in Differentiated Cancer of the Thyroid) trial evaluating the use of investigational agent lenvatinib in the treatment of progressive, radioactive iodine-refractory differentiated thyroid cancer (RAI-refractory DTC) were published online in the New England Journal of Medicine (NEJM). Read more..

TOPICS:

Cumberland Pharmaceuticals: Pipeline Expansion with AERD Drug

February 12, 2015 11:10 am | News | Comments

Cumberland Pharmaceuticals Inc. announced an expansion of its pipeline with a new Phase II development program. The Company has initiated the clinical development of Boxaban (ifetroban) oral capsule for the treatment of aspirin exacerbated respiratory disease (AERD). Read more..

TOPICS:

J&J Projects Aim to Spot Who'll Get a Disease

February 12, 2015 10:59 am | by Associated Press | News | Comments

Imagine being able to identify people likely to develop a particular disease - and then stop it before it starts. This isn't a science fiction tale. It's the ambitious goal of three research projects just launched by Johnson & Johnson's pharmaceutical research arm, Janssen Research & Development, that the company says are aimed at redefining health care. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading